Press Ganey Associates collaborates with HMA to improve patient care

NewsGuard 100/100 Score

Press Ganey Associates, Inc. today announced a broad partnership with Health Management Associates, Inc. (NYSE: HMA) to help measure and improve satisfaction and engagement among patients, employees, and physicians. The company started working with HMA on October 1, 2009.

HMA owns and operates more than 50 general acute-care hospitals, with approximately 8,000 licensed beds, in non-urban communities located throughout the United States.

"This agreement is a sign of our continued commitment to focus on the care and well being of all the communities we serve: our patients, employees, and physicians," said Scott Campbell, vice president, physician and customer development, HMA. "The knowledge gained through this partnership will help us understand how to best align our organization to improve the experiences of each of these important groups."

"We're honored to collaborate with HMA on a comprehensive initiative that will enhance the company's longstanding commitment to delivering outstanding patient care, and developing a rewarding workplace for its employees and physicians," said Richard Siegrist, Press Ganey CEO. "HMA clearly understands the benefits of involving all stakeholders in a successful quality improvement program."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.